Clinicopathologic conference: Hypertension and the Lupus Syndrome—revisited

1970, 49, 519

Elion, 1963, Relationship between metabolic fates and antitumor activities of thiopurines, Cancer Res, 23, 1207

Elion, 1966, Metabolic studies of allopurinol, an inhibitor of xanthine oxidase, Biochem Pharmacol, 15, 863, 10.1016/0006-2952(66)90163-8

Fox, 1970, Depletion of erythrocyte phosphoribosylpyrophosphate in man. A newly observed effect of allopurinol, New Eng J Med, 282, 1177, 10.1056/NEJM197011262832201

Kelley, 1970, Allopurinol: alterations in pyrimidine metabolism in man, Science, 169, 388, 10.1126/science.169.3943.388

Elion, 1963, Potentiation by inhibition of drug degradation: 6-substituted purines and xanthine oxidase, Biochem Pharmacol, 12, 85, 10.1016/0006-2952(63)90012-1

Rundles, 1963, Effects of a xanthine oxidase inhibitor on thiopurine metabolism hyperuricemia and gout, Trans Ass Amer Physicians, 76, 126

DeConti, 1966, Use of allopurinol for prevention and control of hyperuricemia in patients with neoplastic disease, New Eng J Med, 274, 481, 10.1056/NEJM196603032740902